AstraZeneca succeeds in treating lupus in late-stage study - cutting the use of steroids!

Great news on the lupus clinical trial front!

British drug-maker AstraZeneca announced success in treating lupus in this late-stage study.

In their recent trial, AstraZeneca's intravenous drug, anifrolumab, significantly reduced disease activity in patients with lupus.

In fact, more than half of the patients on the treatment were able to reduce their use of steroids - something almost every lupus patient strives for!

You can read more about the results of the study here. Enjoy!


Popular Posts